Search Results 131-140 of 17143 for egfr

  1. Pulmonary Medicine - Clinical trials

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  2. Publications - Jorge A. Trejo-Lopez, M.D. - Mayo Clinic

    EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype? J Neuropathol Exp Neurol. 2025 Nov 1; 84 (11):1059-1062. View PubMed ...

  3. Find cancer clinical trials - Mayo Clinic

    Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...

  4. Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions - Mayo Clinic

    ... eGFR using the Modification of Diet in Renal Disease (MDRD) Study equation is more accurate than a creatinine clearance calculated from serum and urine ...

  5. Health disparities in preventive screenings for African Americans - Mayo Clinic News Network

    Historically, the formulas include a Black race variable which increased eGFR values for this population and overestimated kidney function by up to 16%. This ...

  6. Radiation Oncology - Clinical trials

    ... (eGFR ≥ 60ml/min). A Study of Proton Radiation Divided into Fewer Doses for Low Risk Prostate Cancer. Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose ...

  7. A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    * A histologically or cytologically documented non-squamous cell NSCLC that is locally advanced or metastatic. * A known epidermal growth factor receptor (EGFR) ...

  8. Phase II Single-arm Study of Tepotinib Combined with Cetuximab - Mayo Clinic

    ... (EGFR) antibody targeted therapy due to mesenchymal epithelial transition factor (MET) amplification. Participation eligibility. Participant eligibility ...

  9. Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) 25-55 ml/min/1.73m2 1. If eGFR 45-55 ml/min/1.73m2, then albumin:creatinine ratio ≥300 mg/g or proteinuria ...

  10. A Study Of Radiation Dosimetry, Safety, And Tolerability Of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment In Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer

    ... (eGFR ≥ 60ml/min). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...